Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Flipo

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Molecules (Basel, Switzerland)|October 13, 2021
Molecular Design in Practice: A Review of Selected Projects in a French Research Institute That Illustrates the Link between Chemical Biology and Medicinal ChemistryBenoit Deprez, Damien Bosc, Julie Charton, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Rapid and Efficient Access to Novel Bio-Inspired 3-Dimensional Tricyclic SpiroLactams as Privileged Structures via Meyers' LactamizationSalia Tangara, Léo Faïon, Catherine Piveteau, et al.
Analytical Biochemistry|February 25, 2014
Unconventional surface plasmon resonance signals reveal quantitative inhibition of transcriptional repressor EthR by synthetic ligandsCéline Crauste, Nicolas Willand, Baptiste Villemagne, et al.
Biochimica Et Biophysica Acta. Proteins and Proteomics|December 17, 2018
A comprehensive analysis of the protein-ligand interactions in crystal structures of Mycobacterium tuberculosis EthRAbdalkarim Tanina, Alexandre Wohlkönig, Sameh H Soror, et al.
Pharmaceuticals (Basel, Switzerland)|April 23, 2022
On the Hunt for Next-Generation Antimicrobial Agents: An Online Symposium Organized Jointly by the French Society for Medicinal Chemistry (Société de Chimie Thérapeutique) and the French Microbiology Society (Société Française de Microbiologie) on 9-10 December 2021Kevin Antraygues, Nina Compagne, Francesca Ruggieri, et al.
European Journal of Medicinal Chemistry|July 17, 2023
Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pumpNina Compagne, Juan-Carlos Jiménez-Castellanos, Virginie Meurillon, et al.
ACS Infectious Diseases|February 4, 2020
Fragment-Based Optimized EthR Inhibitors with <i>in Vivo</i> Ethionamide Boosting ActivityBaptiste Villemagne, Arnaud Machelart, Ngoc Chau Tran, et al.
European Journal of Medicinal Chemistry|February 21, 2019
A fragment-based approach towards the discovery of N-substituted tropinones as inhibitors of Mycobacterium tuberculosis transcriptional regulator EthR2Hugues Prevet, Martin Moune, Abdalkarim Tanina, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial AcidificationLéo Faïon, Kamel Djaout, Catalin Pintiala, et al.
Journal of Medicinal Chemistry|December 6, 2022
Tricyclic SpiroLactams Kill Mycobacteria In Vitro and In Vivo by Inhibiting Type II NADH DehydrogenasesSushovan Dam, Salia Tangara, Claire Hamela, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Molecules (Basel, Switzerland)|October 13, 2021
Molecular Design in Practice: A Review of Selected Projects in a French Research Institute That Illustrates the Link between Chemical Biology and Medicinal ChemistryBenoit Deprez, Damien Bosc, Julie Charton, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Rapid and Efficient Access to Novel Bio-Inspired 3-Dimensional Tricyclic SpiroLactams as Privileged Structures via Meyers' LactamizationSalia Tangara, Léo Faïon, Catherine Piveteau, et al.
Analytical Biochemistry|February 25, 2014
Unconventional surface plasmon resonance signals reveal quantitative inhibition of transcriptional repressor EthR by synthetic ligandsCéline Crauste, Nicolas Willand, Baptiste Villemagne, et al.
Biochimica Et Biophysica Acta. Proteins and Proteomics|December 17, 2018
A comprehensive analysis of the protein-ligand interactions in crystal structures of Mycobacterium tuberculosis EthRAbdalkarim Tanina, Alexandre Wohlkönig, Sameh H Soror, et al.
Pharmaceuticals (Basel, Switzerland)|April 23, 2022
On the Hunt for Next-Generation Antimicrobial Agents: An Online Symposium Organized Jointly by the French Society for Medicinal Chemistry (Société de Chimie Thérapeutique) and the French Microbiology Society (Société Française de Microbiologie) on 9-10 December 2021Kevin Antraygues, Nina Compagne, Francesca Ruggieri, et al.
European Journal of Medicinal Chemistry|July 17, 2023
Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pumpNina Compagne, Juan-Carlos Jiménez-Castellanos, Virginie Meurillon, et al.
ACS Infectious Diseases|February 4, 2020
Fragment-Based Optimized EthR Inhibitors with <i>in Vivo</i> Ethionamide Boosting ActivityBaptiste Villemagne, Arnaud Machelart, Ngoc Chau Tran, et al.
European Journal of Medicinal Chemistry|February 21, 2019
A fragment-based approach towards the discovery of N-substituted tropinones as inhibitors of Mycobacterium tuberculosis transcriptional regulator EthR2Hugues Prevet, Martin Moune, Abdalkarim Tanina, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial AcidificationLéo Faïon, Kamel Djaout, Catalin Pintiala, et al.
Journal of Medicinal Chemistry|December 6, 2022
Tricyclic SpiroLactams Kill Mycobacteria In Vitro and In Vivo by Inhibiting Type II NADH DehydrogenasesSushovan Dam, Salia Tangara, Claire Hamela, et al.
Pageof 4